Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - ARGAN INC | c14255e8vk.htm |
| EX-10.1 - EXHIBIT 10.1 - ARGAN INC | c14255exv10w1.htm |
| EX-10.2 - EXHIBIT 10.2 - ARGAN INC | c14255exv10w2.htm |
Exhibit 99.1
Argan, Inc. Sells the Assets of Vitarich Laboratories, Inc. to NBTY Florida, Inc.
March 14, 2011 — Rockville, MD — Argan, Inc. (NYSE AMEX: AGX) today announced that it has sold
substantially all of the assets of Vitarich Laboratories, Inc. (VLI), a wholly-owned subsidiary of
Argan to NBTY Florida, Inc. (NFI).
Under the Agreement, NFI made an initial closing payment of $800,000 and placed $2.3 million in
escrow whose payment is subject to collection of certain accounts receivable by June 30, 2011 and
the sale, use or consumption of inventory prior to December 12, 2011. The Agreement also provides
for NFI to assume responsibility for payment of certain trade payables and accrued expenses of VLI.
About Argan, Inc.
Argan’s primary business is designing and building energy plants through its Gemma Power Systems
subsidiary. These energy plants include traditional gas as well as alternative energy including
biodiesel, ethanol, and renewable energy sources such as wind power and solar. Argan also owns
Southern Maryland Cable, Inc.
Certain matters discussed in this press release may constitute forward-looking statements within
the meaning of the federal securities laws and are subject to risks and uncertainties including,
but not limited to; (1) the Company’s ability to achieve its business strategy while effectively
managing costs and expenses; (2) the Company’s ability to successfully and profitably integrate
acquisitions; and (3) the continued strong performance of the energy sector. Actual results and the
timing of certain events could differ materially from those projected in or contemplated by the
forward-looking statements due to a number of factors detailed from time to time in Argan’s filings
with the Securities and Exchange Commission. In addition, reference is hereby made to cautionary
statements with respect to risk factors set forth in the Company’s most recent reports on Form 10-K
and 10-Q, and other SEC filings.
Company Contact: Rainer Bosselmann 301.315.0027 |
Investor Relations Contact: Arthur Trudel 301.315.9467 |